Functional Correlates of GI Tract Damage After BMT
| Groups . | No. . | Serum LPS (U/mL) . | Serum TNFα (pg/mL) . | |
|---|---|---|---|---|
| Donor . | Treatment . | |||
| (1) B6D2F1 | Control | 15 | 1.75 ± 0.35 | 137 ± 44‡ |
| (2) B6 | Control | 7-9 | 12.20 ± 2.50* | 753 ± 137† |
| (3) B6 | KGF | 15 | 1.60 ± 0.26 | 278 ± 75 |
| Groups . | No. . | Serum LPS (U/mL) . | Serum TNFα (pg/mL) . | |
|---|---|---|---|---|
| Donor . | Treatment . | |||
| (1) B6D2F1 | Control | 15 | 1.75 ± 0.35 | 137 ± 44‡ |
| (2) B6 | Control | 7-9 | 12.20 ± 2.50* | 753 ± 137† |
| (3) B6 | KGF | 15 | 1.60 ± 0.26 | 278 ± 75 |